Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Board Evaluation Review of Medicines and Healthcare products Regulatory Agency

Medicines and Healthcare Products Regulatory Agency

This public procurement record has 1 release in its history.

Award

07 Sep 2026 at 09:19

UK7 - Contract Details Notice
Summary of the contracting process

MHRA commissioned an external review of the effectiveness of its board. The requirement is a business and management consultancy service focused on evaluating board performance and effectiveness. MHRA is the Medicines and Healthcare products Regulatory Agency, a central government public authority based in London, and the work concerns its own board. The procurement is categorised as consultancy and related business management services. The requirement was treated as a single service package rather than being divided into separate areas of work. This suits consultancies that provide independent board evaluations, governance reviews, organisational effectiveness assessments or related advice to public bodies. The work is for MHRA’s organisational governance and board oversight, rather than for the regulation, manufacture or supply of medicines and healthcare products.

The procurement is complete and was awarded through a direct, below-threshold procedure without competition. Praesta Partners LLP was selected as the supplier and the award is active. The contract was signed on 31 August 2026, with delivery running from 1 September 2026 to 31 December 2026. Its value is £35,000 excluding VAT and £42,000 including VAT. The award covered the full single lot for the board evaluation review. The published evaluation basis was therefore the buyer’s direct-award route rather than a competitive scoring exercise. This outcome shows MHRA used a short, focused commissioning route for a defined external review, with the supplier appointed for the complete requirement.

For a consultancy competing for similar work, the award indicates demand for an independent specialist able to assess the effectiveness of a central government agency board and produce a focused governance review. Relevant capability would include board evaluation methodology, public-sector governance, assessment of board effectiveness, evidence-based interviewing or review work, and clear reporting for senior decision-makers. Experience with regulators, government departments or other complex public bodies would help a supplier understand accountability, assurance and the public-interest context. The selected supplier is an SME, showing that this requirement can be delivered by a focused specialist consultancy rather than only by a large professional-services firm. A credible competitor would need to demonstrate senior expertise, independence, discretion and the capacity to complete a contained review to a public-sector standard.

How relevant is this notice?

Notice Information

Notice Title

Board Evaluation Review of Medicines and Healthcare products Regulatory Agency

Notice Description

External review of the effectiveness of Medicines and Healthcare products Regulatory Agency's board.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06f309
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/084197-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Direct
Procurement Method Details
Below threshold - without competition
Tender Suitability
Not specified
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79400000 - Business and management consultancy and related services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£35,000 Under £100K

Notice Dates

Publication Date
7 Sep 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Sep 2026 - 31 Dec 2026 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Medicines and Healthcare Products Regulatory Agency
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Postcode Area
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

Praesta Partners LLP

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...